
Ebenezer O Sackey
Examiner (ID: 17838, Phone: (571)272-0704 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1613, 1201, 1626, 1624, 1621 |
| Total Applications | 2086 |
| Issued Applications | 1598 |
| Pending Applications | 91 |
| Abandoned Applications | 399 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17420186
[patent_doc_number] => 11253616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Small molecules for dual function positron emission tomography (PET) and cell suicide switches
[patent_app_type] => utility
[patent_app_number] => 16/123797
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 39
[patent_no_of_words] => 24806
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123797 | Small molecules for dual function positron emission tomography (PET) and cell suicide switches | Sep 5, 2018 | Issued |
Array
(
[id] => 15813937
[patent_doc_number] => 10632125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => MTH1 inhibitors for treatment of inflammatory and autoimmune conditions
[patent_app_type] => utility
[patent_app_number] => 16/120170
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 74811
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1765
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16120170
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/120170 | MTH1 inhibitors for treatment of inflammatory and autoimmune conditions | Aug 30, 2018 | Issued |
Array
(
[id] => 16085233
[patent_doc_number] => 20200196603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => PESTICIDALLY ACTIVE PYRAZOLE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/638428
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638428
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/638428 | Pesticidally active pyrazole derivatives | Aug 8, 2018 | Issued |
Array
(
[id] => 13928997
[patent_doc_number] => 20190048014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)
[patent_app_type] => utility
[patent_app_number] => 16/059909
[patent_app_country] => US
[patent_app_date] => 2018-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/059909 | Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) | Aug 8, 2018 | Issued |
Array
(
[id] => 16998327
[patent_doc_number] => 11077109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Compounds having antibacterial activity and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/052212
[patent_app_country] => US
[patent_app_date] => 2018-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 43
[patent_no_of_words] => 6636
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16052212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/052212 | Compounds having antibacterial activity and methods of use | Jul 31, 2018 | Issued |
Array
(
[id] => 16312257
[patent_doc_number] => 20200290995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => Process for the Preparation of Crystalline Ridinilazole Using Acid Addition Salts
[patent_app_type] => utility
[patent_app_number] => 16/652435
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8668
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652435
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652435 | Process for the preparation of crystalline ridinilazole using acid addition salts | Jul 26, 2018 | Issued |
Array
(
[id] => 13840413
[patent_doc_number] => 20190023691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-24
[patent_title] => PROCESSES FOR THE PREPARATION OF PYRAZOLE DERIVATIVES USEFUL AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR
[patent_app_type] => utility
[patent_app_number] => 16/045375
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21382
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045375
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045375 | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A serotonin receptor | Jul 24, 2018 | Issued |
Array
(
[id] => 16335575
[patent_doc_number] => 10786513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-29
[patent_title] => Use of GABA
[patent_app_type] => utility
[patent_app_number] => 16/045193
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 38
[patent_no_of_words] => 16156
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045193 | Use of GABA | Jul 24, 2018 | Issued |
Array
(
[id] => 13823847
[patent_doc_number] => 20190015408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => CRYSTALLIZATION PROCESS OF ARIPIPRAZOLE DERIVATIVES IN EXTENDED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
[patent_app_type] => utility
[patent_app_number] => 16/043721
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13283
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16043721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/043721 | Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia | Jul 23, 2018 | Issued |
Array
(
[id] => 16275531
[patent_doc_number] => 10758538
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-09-01
[patent_title] => Heat shock protein binding compounds, compositions, and methods for making and using same
[patent_app_type] => utility
[patent_app_number] => 16/037160
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 58842
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037160
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/037160 | Heat shock protein binding compounds, compositions, and methods for making and using same | Jul 16, 2018 | Issued |
Array
(
[id] => 13536409
[patent_doc_number] => 20180319748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/035502
[patent_app_country] => US
[patent_app_date] => 2018-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16035502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/035502 | Kinase inhibitors | Jul 12, 2018 | Issued |
Array
(
[id] => 15363541
[patent_doc_number] => 20200017535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => METAL COMPLEXES AND METHODS OF PREPARING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/033754
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033754 | Metal complexes and methods of preparing the same | Jul 11, 2018 | Issued |
Array
(
[id] => 17392440
[patent_doc_number] => 11241428
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-08
[patent_title] => Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and/or 2(HDAC1-2)
[patent_app_type] => utility
[patent_app_number] => 16/629457
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13317
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 374
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629457 | Heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and/or 2(HDAC1-2) | Jul 8, 2018 | Issued |
Array
(
[id] => 13548647
[patent_doc_number] => 20180325871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => ANTIMITOTIC AMIDES FOR THE TREATMENT OF CANCER AND PROLIFERATIVE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/024407
[patent_app_country] => US
[patent_app_date] => 2018-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16024407
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/024407 | Antimitotic amides for the treatment of cancer and proliferative disorders | Jun 28, 2018 | Issued |
Array
(
[id] => 14731269
[patent_doc_number] => 10385023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-20
[patent_title] => Compounds, compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/021418
[patent_app_country] => US
[patent_app_date] => 2018-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25100
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16021418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/021418 | Compounds, compositions and methods | Jun 27, 2018 | Issued |
Array
(
[id] => 14338681
[patent_doc_number] => 20190151313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => SOLID FORMS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/015645
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015645
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015645 | Solid forms of an epidermal growth factor receptor kinase inhibitor | Jun 21, 2018 | Issued |
Array
(
[id] => 15360741
[patent_doc_number] => 20200016135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => AMIDE DERIVATIVES AS NAV1.7 AND NAV1.8 BLOCKERS
[patent_app_type] => utility
[patent_app_number] => 16/301691
[patent_app_country] => US
[patent_app_date] => 2018-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301691
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301691 | Amide derivatives as Nav1.7 and Nav1.8 blockers | Jun 19, 2018 | Issued |
Array
(
[id] => 16090229
[patent_doc_number] => 20200199101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => SYK INHIBITOR AND USE METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 16/619646
[patent_app_country] => US
[patent_app_date] => 2018-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26250
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16619646
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/619646 | Syk inhibitor and use method therefor | Jun 13, 2018 | Issued |
Array
(
[id] => 16009083
[patent_doc_number] => 20200179384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => N2,N4-DIPHENYLPYRIMIDINE-2,4-DIAMINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/622057
[patent_app_country] => US
[patent_app_date] => 2018-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622057
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622057 | N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer | Jun 11, 2018 | Issued |
Array
(
[id] => 13461575
[patent_doc_number] => 20180282330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => METHODS OF PREPARING INHIBITORS OF INFLUENZA VIRUSES REPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/000939
[patent_app_country] => US
[patent_app_date] => 2018-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16000939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/000939 | Methods of preparing inhibitors of influenza viruses replication | Jun 5, 2018 | Issued |